2 Result: Alvotech
Alvotech, Teva, JNJ Settle on AVT04; Teck Resources Evaluating Glencore Proposal
June 12th, 2023
Alvotech (Nasdaq: ALVO) and an affiliate of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) have announced a settlement and license agreement with Johnson & Johnson (NYSE: JNJ) concerning AVT04, Alvotech's proposed biosimilar to Stelara (ustekinumab. Read more
The Week On The Horizon: Brady Corporation, Canadian Solar, Canada Goose, Alvotech
May 14th, 2023
On Thursday, May 18, investors and analysts will be keeping a close eye on several notable companies set to report their financial results. Brady Corporation (NYSE: BRC) is expected to release its fiscal 2023 third quarter financial results . Read more
Want To Find Some News?
News By Industries
Recent Post
-
Johnson & Johnson, Charles Schwab, Halliburton: Earnings Preview
January 18th, 2026Key Earnings Ahead for Netflix, Fastenal, and U.S. Bancorp
January 18th, 2026Louisville Thunder Appoints Veteran Coach Mike Reed to Lead Program
January 15th, 2026FDA Approves First Treatment for Children With Menkes Disease
January 13th, 2026
Member Login